Clinical Trial

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy

Study acronym: ACE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the feasibility and preliminary efficacy of a combined acupuncture and exercise intervention for the management of chemotherapy-induced peripheral neuropathy (CIPN) in participants with metastatic bladder cancer receiving enfortumab vedotin (EV) and pembrolizumab (Pembro). The names of the two study groups in this research study are: * Acupuncture + Virtual Exercise (AVE) * Virtual Exercise Only (VE)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-17.
Trial Details
NCT Number NCT07548476
Lead Sponsor Dana-Farber Cancer Institute
Conditions Metastatic Bladder Cancer, Peripheral Neuropathy, Advanced Urothelial Cancer, Metastatic Urothelial Cancer
Enrollment 50 participants
Start Date 2026-10-02
Primary Completion 2027-03-02 (estimated)
Study Completion 2027-03-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-04